Contrasting Polarityte (COOL) & Its Rivals
Polarityte (NASDAQ: COOL) is one of 192 public companies in the “Prepackaged software” industry, but how does it compare to its peers? We will compare Polarityte to related companies based on the strength of its analyst recommendations, valuation, risk, institutional ownership, profitability, earnings and dividends.
Insider & Institutional Ownership
43.1% of Polarityte shares are owned by institutional investors. Comparatively, 59.0% of shares of all “Prepackaged software” companies are owned by institutional investors. 43.3% of Polarityte shares are owned by company insiders. Comparatively, 21.6% of shares of all “Prepackaged software” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
This is a breakdown of recent ratings for Polarityte and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Polarityte currently has a consensus price target of $65.00, suggesting a potential upside of 275.07%. As a group, “Prepackaged software” companies have a potential upside of 1.34%. Given Polarityte’s stronger consensus rating and higher possible upside, equities analysts clearly believe Polarityte is more favorable than its peers.
Volatility and Risk
Polarityte has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Comparatively, Polarityte’s peers have a beta of -19.85, suggesting that their average stock price is 2,085% less volatile than the S&P 500.
Earnings & Valuation
This table compares Polarityte and its peers revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Polarityte||$6.69 million||-$130.82 million||-0.65|
|Polarityte Competitors||$1.77 billion||$188.59 million||-4.09|
Polarityte’s peers have higher revenue and earnings than Polarityte. Polarityte is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
This table compares Polarityte and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Polarityte beats its peers on 8 of the 13 factors compared.
PolarityTE, Inc. engages in the regenerative medicine and tissue engineering platform. The firm seeks to develop and obtain regulatory approval for technology that will utilize a patient’s own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. Its products include SkinTE, OsteoTE, AngioTE, MyoTE, CartTe, AdiposeTE, and NeuralTE. The company was founded in 2004 and is headquartered in Salt Lake City, UT.
Receive News & Ratings for Polarityte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarityte and related companies with MarketBeat.com's FREE daily email newsletter.